{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T21:04:46Z","timestamp":1791493486801,"version":"4.3.4"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Translational Autoimmunity"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jtauto.2026.100354","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T19:11:50Z","timestamp":1769713910000},"page":"100354","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Antinuclear antibody targets in autoimmune hepatitis and drug-induced liver injury: Diagnostic relevance of nucleosome antibodies"],"prefix":"10.1016","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5027-3432","authenticated-orcid":false,"given":"Mirjam","family":"Kolev","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mich\u00e8le","family":"Freiburghaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Stirnimann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henning","family":"Nilius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5378-3825","authenticated-orcid":false,"given":"Martin","family":"Wartenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliette","family":"Schlatter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Nagler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5772-6342","authenticated-orcid":false,"given":"Michael P.","family":"Horn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2707-765X","authenticated-orcid":false,"given":"Nasser","family":"Semmo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.jtauto.2026.100354_bib1","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1053\/j.gastro.2013.02.006","article-title":"Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland","volume":"144","author":"Bjornsson","year":"2013","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.jtauto.2026.100354_bib2","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jhep.2025.03.017","article-title":"EASL clinical practice guidelines on the management of autoimmune hepatitis","volume":"83","year":"2025","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.jtauto.2026.100354_bib3","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jhep.2015.06.030","article-title":"EASL clinical practice guidelines: autoimmune hepatitis","volume":"63","year":"2015","journal-title":"J. Hepatol."},{"issue":"6","key":"10.1016\/j.jtauto.2026.100354_bib4","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1016\/j.jhep.2020.07.023","article-title":"Second-line and third-line therapy for autoimmune hepatitis: a position statement from the european reference network on hepatological diseases and the international autoimmune hepatitis group","volume":"73","author":"Lohse","year":"2020","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.jtauto.2026.100354_bib5","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.jhep.2004.08.002","article-title":"Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the international autoimmune hepatitis group","volume":"41","author":"Vergani","year":"2004","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.jtauto.2026.100354_bib6","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/hepr.12130","article-title":"Anti-nucleosome autoantibodies as markers for autoimmune hepatitis and their correlation with disease activity","volume":"44","author":"Yokokawa","year":"2014","journal-title":"Hepatol. Res."},{"issue":"5","key":"10.1016\/j.jtauto.2026.100354_bib7","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1440-1746.1998.tb00673.x","article-title":"Characterization of anti-histone antibodies in patients with type 1 autoimmune hepatitis","volume":"13","author":"Chen","year":"1998","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.jtauto.2026.100354_bib8","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/0168-8278(95)80308-4","article-title":"Frequency and significance of antibodies to histones in autoimmune hepatitis","volume":"23","author":"Czaja","year":"1995","journal-title":"J. Hepatol."},{"issue":"6","key":"10.1016\/j.jtauto.2026.100354_bib9","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1023\/A:1018880429469","article-title":"Antibodies to Ro\/La, Cenp-B, and snRNPs antigens in autoimmune hepatitis of North America versus Asia: patterns of immunofluorescence, ELISA reactivities, and HLA association","volume":"43","author":"Parveen","year":"1998","journal-title":"Dig. Dis. Sci."},{"issue":"3","key":"10.1016\/j.jtauto.2026.100354_bib10","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/hep.510260306","article-title":"Antibodies to single-stranded and double-stranded DNA in antinuclear antibody-positive type 1-autoimmune hepatitis","volume":"26","author":"Czaja","year":"1997","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.jtauto.2026.100354_bib11","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.cgh.2016.05.043","article-title":"Features of autoimmune hepatitis in patients with drug-induced liver injury","volume":"15","author":"de Boer","year":"2017","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.jtauto.2026.100354_bib12","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3350\/cmh.2012.18.2.213","article-title":"The clinical features of drug-induced liver injury observed through liver biopsy: focus on relevancy to autoimmune hepatitis","volume":"18","author":"Ju","year":"2012","journal-title":"Clin. Mol. Hepatol."},{"issue":"3","key":"10.1016\/j.jtauto.2026.100354_bib13","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/hep.24481","article-title":"The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury","volume":"54","author":"Suzuki","year":"2011","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.jtauto.2026.100354_bib14","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1111\/hepr.13532","article-title":"Histopathological analysis of autoimmune hepatitis with \"acute\" presentation: differentiation from drug-induced liver injury","volume":"50","author":"Tsutsui","year":"2020","journal-title":"Hepatol. Res."},{"issue":"8","key":"10.1016\/j.jtauto.2026.100354_bib15","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1111\/liv.15623","article-title":"Clinical presentation, causative drugs and outcome of patients with autoimmune features in two prospective DILI registries","volume":"43","author":"Garcia-Cortes","year":"2023","journal-title":"Liver Int."},{"issue":"12","key":"10.1016\/j.jtauto.2026.100354_bib16","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.dld.2014.08.040","article-title":"Clinical features and outcomes of patients with drug-induced autoimmune hepatitis: a retrospective cohort study","volume":"46","author":"Licata","year":"2014","journal-title":"Dig. Liver Dis."},{"issue":"1","key":"10.1016\/j.jtauto.2026.100354_bib17","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.22322","article-title":"Simplified criteria for the diagnosis of autoimmune hepatitis","volume":"48","author":"Hennes","year":"2008","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.jtauto.2026.100354_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17010014","article-title":"RUCAM in drug and herb induced liver injury: the update","volume":"17","author":"Danan","year":"2015","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.jtauto.2026.100354_bib19","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","article-title":"Histological grading and staging of chronic hepatitis","volume":"22","author":"Ishak","year":"1995","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.jtauto.2026.100354_bib20","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/hep.510240201","article-title":"An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative study group","volume":"24","author":"Bedossa","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.jtauto.2026.100354_bib21","doi-asserted-by":"crossref","first-page":"412","DOI":"10.3389\/fimmu.2015.00412","article-title":"Report of the first international consensus on standardized nomenclature of antinuclear antibody HEp-2 cell patterns 2014-2015","volume":"6","author":"Chan","year":"2015","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.jtauto.2026.100354_bib26","doi-asserted-by":"crossref","DOI":"10.1186\/ar2548","article-title":"Limited reliability of the indirect immunofluorescence technique for the detection of anti-Rib-P antibodies","volume":"10","author":"Mahler","year":"2008","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jtauto.2026.100354_bib22","doi-asserted-by":"crossref","first-page":"609","DOI":"10.3389\/fimmu.2018.00609","article-title":"Autoantibodies in autoimmune liver disease-clinical and diagnostic relevance","volume":"9","author":"Sebode","year":"2018","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.jtauto.2026.100354_bib23","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1002\/hep4.1582","article-title":"Exploratory study of autoantibody profiling in drug-induced liver injury with an autoimmune phenotype","volume":"4","author":"Lammert","year":"2020","journal-title":"Hepatol. Commun."},{"issue":"2","key":"10.1016\/j.jtauto.2026.100354_bib24","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jhep.2020.07.032","article-title":"Update of the simplified criteria for autoimmune hepatitis: evaluation of the methodology for immunoserological testing","volume":"74","author":"Galaski","year":"2021","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.jtauto.2026.100354_bib25","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.jhep.2023.04.033","article-title":"Nomenclature, diagnosis and management of drug-induced autoimmune-like hepatitis (DI-ALH): an expert opinion meeting report","volume":"79","author":"Andrade","year":"2023","journal-title":"J. Hepatol."}],"container-title":["Journal of Translational Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589909026000079?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589909026000079?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T01:23:12Z","timestamp":1781659392000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589909026000079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":26,"alternative-id":["S2589909026000079"],"URL":"https:\/\/doi.org\/10.1016\/j.jtauto.2026.100354","relation":{},"ISSN":["2589-9090"],"issn-type":[{"value":"2589-9090","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antinuclear antibody targets in autoimmune hepatitis and drug-induced liver injury: Diagnostic relevance of nucleosome antibodies","name":"articletitle","label":"Article Title"},{"value":"Journal of Translational Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtauto.2026.100354","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100354"}}